R J Henning, L Feliciano, C M Coers
Index: Cardiovasc. Res. 32(5) , 846-53, (1996)
Full Text: HTML
To determine the effects of vasoactive intestinal peptide, released from the right and left vagal nerves, on ventricular contraction, relaxation, and heart rate.The muscarinic and beta-adrenergic receptors were blocked with atropine and propranolol, and afterload was controlled in 48 anesthetized, open-chest mongrel dogs. Experiments were performed in the absence (Series 1, 10 dogs) and in the presence (Series 2, 22 dogs) of a controlled heart rate and prior to and after the administration of a sensitive and selective vasoactive intestinal peptide antagonist (Series 3, 16 dogs).Right ventricular contraction (+dp/dtmax), relaxation (-dp/dtmin) and heart rate increased significantly during 20 Hz vagal nerve stimulation for 5 min. Vagal nerve stimulation in Series 1 increased right ventricular +dp/dtmax by 28% from a control value of 480 +/- 11 (P < 0.001) and right ventricular -dp/dtmin by 23% from a control value of 341 +/- 11 (P < 0.002). Left ventricular +dp/dtmax and -dp/dtmin increased slightly but not significantly. Vagal nerve stimulation also increased the heart rate by 29% from a control value of 149 +/- 2 (P < 0.001). During controlled heart rate in Series 2, vagal nerve stimulation at 20 Hz consistently increased right ventricular +dp/dtmax and -dp/dtmin comparable to Series 1 experiments but did not increase left ventricular +dp/dtmax or -dp/dtmin. Injection of the vasoactive intestinal peptide antagonist [4Cl-DPhe6, Leu17]VIP into the right coronary artery of 16 dogs in Series 3 did not affect right ventricular +dp/dtmax, -dp/dtmin, or heart rate. However, this antagonist substantially decreased the vagal-induced increases in right ventricular +dp/dtmax, -dp/dtmin, and heart rate by 85, 63, and 71% (P < 0.005), respectively.The present experiments suggest that vagal nerve stimulation releases vasoactive intestinal peptide (VIP) or a "VIP-like substance' that significantly increases right ventricular contraction, relaxation, and heart rate.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
(p-Chloro-D-Phe6,Leu17)-VIP (human, mouse, rat) trifluoroacetate salt
CAS:102805-45-8 |
C148H239ClN44O42 |
Vasoactive intestinal polypeptide antagonists attenuate vaga...
1995-10-01 [Am. J. Physiol. 269(4 Pt 2) , H1467-72, (1995)] |
Pituitary adenylate cyclase-activating peptide stimulates cy...
1996-05-01 [J. Endocrinol. 149 , 287, (1996)] |
Homeostatic and therapeutic roles of VIP in smooth muscle fu...
2009-10-01 [Am. J. Physiol. Gastrointest. Liver Physiol. 297(4) , G716-25, (2009)] |
Enhancement by atropine of the pancreatic exocrine secretion...
1993-09-01 [J. Physiol. 469 , 443-57, (1993)] |
The effects of PACAP and VIP on guinea pig tracheal smooth m...
1994-01-01 [Peptides 15(7) , 1237-41, (1994)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved